GASTROINTESTINAL NEUROENDOCRINE TUMOR
Clinical trials for GASTROINTESTINAL NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called BL-M14D1 in 120 patients with advanced small cell lung cancer and other neuroendocrine cancers that have spread and stopped responding to standard treatments. The main goals are to find the safest dose and see how the body proce…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New oral drug trial offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing an experimental oral medication called ESK981 for people with advanced pancreatic cancer and certain neuroendocrine cancers that have stopped responding to standard treatments. The trial will enroll 66 patients across three groups to see if taking ESK981 on …
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC